# Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer

> **NCT06706557** · — · RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 30 (estimated)

## Conditions studied

- Advanced Metastatic Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06706557
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-11
- **Primary completion:** 2026-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06706557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06706557, "Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06706557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*